Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 189,676,160
  • Shares Outstanding, K 1,738,872
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,735 M
  • EBITDA $ 12,953 M
  • 60-Month Beta 0.75
  • Price/Sales 4.24
  • Price/Cash Flow 17.55
  • Price/Book 3.67

Options Overview Details

View History
  • Implied Volatility 22.96% (-0.08%)
  • Historical Volatility 34.24%
  • IV Percentile 58%
  • IV Rank 23.45%
  • IV High 42.50% on 04/07/25
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 7) 2.50 (2.25%)
  • Put/Call Vol Ratio 1.44
  • Today's Volume 30,921
  • Volume Avg (30-Day) 46,890
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 215,821
  • Open Int (30-Day) 190,375
  • Expected Range 108.33 to 113.33

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.15
  • Number of Estimates 9
  • High Estimate 1.17
  • Low Estimate 1.13
  • Prior Year 1.09
  • Growth Rate Est. (year over year) +5.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
105.27 +5.28%
on 01/28/26
128.60 -13.82%
on 01/07/26
-16.95 (-13.26%)
since 01/06/26
3-Month
105.27 +5.28%
on 01/28/26
132.02 -16.05%
on 11/18/25
-14.12 (-11.30%)
since 11/06/25
52-Week
105.27 +5.28%
on 01/28/26
141.23 -21.53%
on 03/04/25
-17.39 (-13.56%)
since 02/06/25

Most Recent Stories

More News
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

ABBOTT PARK, Ill. , Feb. 6, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new clinical data from two late-breaking presentations at AF Symposium in Boston (February 5-7, 2026) that demonstrate...

ABT : 110.83 (+1.60%)
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal

AbbVie is on track to grow, drive cash flow, and pay a healthy dividend for the long term: institutions and analysts are accumulating this stock.

ABT : 110.83 (+1.60%)
ABBV : 223.43 (+2.01%)
Do Wall Street Analysts Like Abbott Laboratories Stock?

While Abbott Laboratories has underperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

ABT : 110.83 (+1.60%)
XLV : 157.71 (+1.85%)
$SPX : 6,932.30 (+1.97%)
These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?

Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.

HUM : 193.94 (+0.20%)
ROP : 362.42 (+3.25%)
ABT : 110.83 (+1.60%)
$SPX : 6,932.30 (+1.97%)
5 Insightful Analyst Questions From Abbott Laboratories’s Q4 Earnings Call

5 Insightful Analyst Questions From Abbott Laboratories’s Q4 Earnings Call

ABT : 110.83 (+1.60%)
Is Abbott’s January Pullback a Good Time to Buy? 

Abbott Laboratories' January price pullback is a signal to load up on shares; this Dividend Aristocrat is growing its business and driving cash flow.

ABT : 110.83 (+1.60%)
Nasdaq Futures Fall as Intel Sinks on Disappointing Outlook, U.S. PMI Data in Focus

March Nasdaq 100 E-Mini futures (NQH26) are trending down -0.20% this morning as a lackluster forecast from semiconductor giant Intel weighed on sentiment.

META : 661.46 (-1.31%)
NVDA : 185.41 (+7.87%)
AMAT : 322.51 (+6.09%)
TSLA : 411.11 (+3.50%)
ABT : 110.83 (+1.60%)
INTC : 50.59 (+4.87%)
DDOG : 111.69 (+4.65%)
NQH26 : 25,163.25s (+2.08%)
AMD : 208.44 (+8.28%)
ARM : 123.70 (+11.56%)
ISRG : 488.15 (+2.48%)
ERICB.S.DX : 99.840 (+0.48%)
ABT Q4 Deep Dive: Nutrition Weakness and Innovation Shape 2026 Outlook

ABT Q4 Deep Dive: Nutrition Weakness and Innovation Shape 2026 Outlook

ABT : 110.83 (+1.60%)
Stocks Settle Higher as Global Tensions Cool and the Economy Expands

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.76%. March E-mini...

GOOGL : 322.86 (-2.53%)
SPHR : 93.21 (+5.43%)
ANET : 137.49 (+6.85%)
AAPL : 278.12 (+0.80%)
HBAN : 19.27 (+1.31%)
MBLY : 8.71 (+3.69%)
DDOG : 111.69 (+4.65%)
$IUXX : 25,075.77 (+2.15%)
ASML : 1,413.01 (+4.66%)
ZNH26 : 112-035s (-0.01%)
MSFT : 401.14 (+1.90%)
TSLA : 411.11 (+3.50%)
Why Abbott Laboratories (ABT) Shares Are Sliding Today

Why Abbott Laboratories (ABT) Shares Are Sliding Today

ABT : 110.83 (+1.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 113.71
2nd Resistance Point 112.38
1st Resistance Point 111.61
Last Price 110.83
1st Support Level 109.50
2nd Support Level 108.17
3rd Support Level 107.40

See More

52-Week High 141.23
Fibonacci 61.8% 127.49
Fibonacci 50% 123.25
Fibonacci 38.2% 119.01
Last Price 110.83
52-Week Low 105.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar